Chief Medical Officer
Pathway Healthcare, Alabama
Stephen M. Taylor, MD, MPH, DFAPA, DFASAM is the Chief Medical Officer of Pathway Healthcare, a company that operates 13 outpatient mental health and addiction treatment offices across Alabama, Mississippi, Tennessee, and Texas. Dr. Taylor is board-certified in psychiatry, child and adolescent psychiatry, addiction psychiatry, and addiction medicine. Dr. Taylor is in his 15th season as the Medical Director of the Player Assistance/Anti-Drug Program of the National Basketball Association (NBA) and the National Basketball Players Association (NBPA).
Dr. Taylor is a Distinguished Fellow of the American Psychiatric Association, and a Distinguished Fellow of the American Society of Addiction Medicine (DFASAM). He is Vice Chair of ASAM’s Legislative Advocacy Committee and serves on ASAM’s Public Policy Committee. He is co-chair of ASAM’s Writing Subcommittee on Advancing Racial Justice, which drafted ASAM’s Public Policy Statement on Advancing Racial Justice in Addiction Medicine. He also chairs ASAM’s Delegation to the AMA House of Delegates and is a member of the ASAM Board of Directors.
Dr. Taylor is a certified Medical Review Officer (MRO) and serves on the Board of Directors of the Medical Review Officer Certification Council (MROCC). He also serves on the Drug Testing Advisory Board (DTAB) of the Center for Substance Abuse Prevention of the Substance Abuse and Mental Health Services Administration (SAMHSA), and he serves on the Board of Directors of the Addiction Prevention Coalition, a non-profit community organization in Birmingham, AL.
An honors graduate of Harvard College, with a Master of Public Health degree from the Harvard School of Public Health and a medical degree from Howard University College of Medicine, Dr. Taylor completed “Triple Board” residency in pediatrics, psychiatry, and child and adolescent psychiatry at the Albert Einstein College of Medicine/Bronx Municipal Hospital Center, then completed a fellowship in addiction psychiatry at NYU School of Medicine/Bellevue Hospital Center.
Disclosure information not submitted.
Saturday, April 2, 2022
8:00 PM – 9:00 PM ET
